Insulin resistance and the long-term consequences of polycystic ovary syndrome (Q37833622)

24 August 2017

1 reference

title

Insulin resistance and the long-term consequences of polycystic ovary syndrome (English)

1 reference

polycystic ovary syndrome

24 August 2017

1 reference

1 reference

1 reference

1 reference

R K Bhathena

1

1 reference

24 August 2017

1 January 2011

1 reference

Journal of Obstetrics and Gynaecology

24 August 2017

1 reference

24 August 2017

31

1 reference

24 August 2017

2

1 reference

24 August 2017

105-110

1 reference

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

24 August 2017

1 reference

https://api.crossref.org/works/10.3109%2F01443615.2010.539722

Androgen excess in women: experience with over 1000 consecutive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01443615.2010.539722

Pregnancy outcomes in women with gestational diabetes treated with metformin or insulin: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01443615.2010.539722

Polycystic ovary syndrome and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01443615.2010.539722

Ultrasound assessment of the polycystic ovary: international consensus definitions.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01443615.2010.539722

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01443615.2010.539722

Effect of rosiglitazone on insulin resistance, growth factors, and reproductive disturbances in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01443615.2010.539722

Assessment of insulin sensitivity in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01443615.2010.539722

Therapeutic options in the polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01443615.2010.539722

New concepts in human sperm-zona pellucida interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01443615.2010.539722

Risk factors for coronary artery disease in lean and obese women with the polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01443615.2010.539722

A systematic review of the reproductive system effects of metformin in patients with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01443615.2010.539722

Glucose-to-insulin ratio rather than sex hormone-binding globulin and adiponectin levels is the best predictor of insulin resistance in nonobese women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01443615.2010.539722

Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01443615.2010.539722

Polycystic Ovary Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01443615.2010.539722

Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01443615.2010.539722

Androgen response to endogenous insulin secretion during the frequently sampled intravenous glucose tolerance test in normal and hyperandrogenic women

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01443615.2010.539722

Efficacy of the combination ethinyl oestradiol and cyproterone acetate on endocrine, clinical and ultrasonographic profile in polycystic ovarian syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01443615.2010.539722

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01443615.2010.539722

Continuing metformin throughout pregnancy in women with polycystic ovary syndrome appears to safely reduce first-trimester spontaneous abortion: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01443615.2010.539722

Incidence and treatment of metabolic syndrome in newly referred women with confirmed polycystic ovarian syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01443615.2010.539722

Metformin therapy throughout pregnancy reduces the development of gestational diabetes in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01443615.2010.539722

The importance of insulin resistance in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01443615.2010.539722

Pregnancy outcome in women with PCOS and in controls matched by age and weight

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01443615.2010.539722

Medical staff need to be aware of major incident planning.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01443615.2010.539722

Polycystic ovary syndrome and endometrial carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01443615.2010.539722

Effect of troglitazone on endocrine and ovulatory performance in women with insulin resistance-related polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01443615.2010.539722

Pregnancies following use of metformin for ovulation induction in patients with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01443615.2010.539722

The long term health consequences of polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01443615.2010.539722

Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01443615.2010.539722

Metformin therapy improves ovulatory rates, cervical scores, and pregnancy rates in clomiphene citrate-resistant women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01443615.2010.539722

The prevalence of polycystic ovaries in women with a history of gestational diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01443615.2010.539722

Comparative tolerability profiles of oral antidiabetic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01443615.2010.539722

Metformin and lactic acidosis in diabetic humans

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01443615.2010.539722

Polycystic ovary syndrome and cardiovascular disease: a premature association?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01443615.2010.539722

Clomiphene, Metformin, or Both for Infertility in the Polycystic Ovary Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01443615.2010.539722

Metformin in polycystic ovary syndrome: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01443615.2010.539722

Hyperinsulinemia in polycystic ovary syndrome correlates with increased cardiovascular risk independent of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01443615.2010.539722

Diagnosing insulin resistance in the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01443615.2010.539722

Obstetric outcome in women with polycystic ovarian syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01443615.2010.539722

Dietary composition in restoring reproductive and metabolic physiology in overweight women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01443615.2010.539722

Metabolic features of the reproductive phenotypes of polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01443615.2010.539722

Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01443615.2010.539722

Strategies for the use of insulin-sensitizing drugs to treat infertility in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01443615.2010.539722

Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01443615.2010.539722

The role of lifestyle modification in polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01443615.2010.539722

Relative risk of conversion from normoglycaemia to impaired glucose tolerance or non-insulin dependent diabetes mellitus in polycystic ovarian syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01443615.2010.539722

Insulin-sensitizing agents in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01443615.2010.539722

The impact of obesity on reproduction in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01443615.2010.539722

Mortality of women with polycystic ovary syndrome at long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01443615.2010.539722

Lipids and lipoprotein subfractions in women with PCOS: relationship to metabolic and endocrine parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01443615.2010.539722

Impaired glucose tolerance in pregnant women with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01443615.2010.539722

Polycystic ovary syndrome: a risk factor for cardiovascular disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01443615.2010.539722

Banting lecture 1988. Role of insulin resistance in human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01443615.2010.539722

Polycystic ovaries and associated metabolic abnormalities in Indian subcontinent Asian women.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01443615.2010.539722

Selective effects of pioglitazone on insulin and androgen abnormalities in normo- and hyperinsulinaemic obese patients with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01443615.2010.539722

Polycystic ovary syndrome: syndrome XX?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01443615.2010.539722

Should patients with polycystic ovarian syndrome be treated with metformin?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01443615.2010.539722

Prevention of diabetes and cardiovascular disease in women with PCOS: treatment with insulin sensitizers

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01443615.2010.539722

Risk of metabolic complications in the new PCOS phenotypes based on the Rotterdam criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01443615.2010.539722

A randomized trial of the effects of two types of short-term hypocaloric diets on weight loss in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01443615.2010.539722

Consensus on infertility treatment related to polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01443615.2010.539722

The pathophysiology of polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01443615.2010.539722

Assessment of glucose tolerance and pregnancy outcome of polycystic ovary patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01443615.2010.539722

Clinical manifestations and insulin resistance (IR) in polycystic ovary syndrome (PCOS) among South Asians and Caucasians: is there a difference?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01443615.2010.539722

Cardiovascular disease in women with polycystic ovary syndrome at long-term follow-up: a retrospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01443615.2010.539722

Long-term health consequences of PCOS.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01443615.2010.539722

Obesity and the polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01443615.2010.539722

10.3109/01443615.2010.539722

21 January 2018

Identifiers

DOI

1 reference

24 August 2017

1 reference

PubMed ID

21281021